- The collaboration will use AI to identify potential biological targets and therapies that could be repurposed for dengue to prevent disease progression - Dengue is a climate-sensitive
/PRNewswire/ BenevolentAI, a leading clinical-stage AI drug discovery company, has expanded its AI-driven drug discovery collaboration with AstraZeneca,.
/PRNewswire/ BenevolentAI, a leading clinical-stage AI drug discovery company, has expanded its AI-driven drug discovery collaboration with AstraZeneca,.
Two novel targets identified through the existing collaboration have already been added to AstraZeneca's portfolio LONDON, Jan. 13, 2022 /PRNewswire/ BenevolentAI, a leading clinical-stage